- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有165家主力机构披露2025-06-30报告期持股数据，持仓量总计2.98亿股，占流通A股52.58%
- 波段诊断：
-
技术面诊股
诊断结果：4.6技术面打败了9%的股票
技术面评分前10的股票
近期的平均成本为16.07元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为16.07元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"16.07","date":1757925064,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2025.09.16","stock":"-1.41","trade":"0.68","ind":"0.04"},{"date":"2025.09.15","stock":"-0.31","trade":"-0.41","ind":"-0.26"},{"date":"2025.09.12","stock":"-1.80","trade":"-0.31","ind":"-0.12"},{"date":"2025.09.11","stock":"-0.89","trade":"0.43","ind":"1.65"},{"date":"2025.09.10","stock":"-0.36","trade":"0.02","ind":"0.13"},{"date":"2025.09.09","stock":"-2.66","trade":"-1.27","ind":"-0.51"},{"date":"2025.09.08","stock":"1.23","trade":"1.30","ind":"0.38"},{"date":"2025.09.05","stock":"2.03","trade":"1.12","ind":"1.24"},{"date":"2025.09.04","stock":"-2.10","trade":"-0.37","ind":"-1.25"},{"date":"2025.09.03","stock":"-2.06","trade":"-1.55","ind":"-1.16"},{"date":"2025.09.02","stock":"0.58","trade":"-1.12","ind":"-0.45"},{"date":"2025.09.01","stock":"1.58","trade":"1.10","ind":"0.46"},{"date":"2025.08.29","stock":"-0.70","trade":"-0.16","ind":"0.37"},{"date":"2025.08.28","stock":"-4.39","trade":"-0.71","ind":"1.14"},{"date":"2025.08.27","stock":"-4.10","trade":"-2.68","ind":"-1.76"},{"date":"2025.08.26","stock":"-0.63","trade":"-0.03","ind":"-0.39"},{"date":"2025.08.25","stock":"0.05","trade":"0.83","ind":"1.51"},{"date":"2025.08.22","stock":"0.69","trade":"-0.41","ind":"1.45"},{"date":"2025.08.21","stock":"-3.94","trade":"-0.21","ind":"0.13"},{"date":"2025.08.20","stock":"-1.51","trade":"0.26","ind":"1.04"},{"date":"2025.08.19","stock":"9.98","trade":"1.38","ind":"-0.02"}]
康缘药业,上证指数,中药指数
压力支撑
该股压力位为16.09元，支撑位为15.92元。
[{"text":"\u538b\u529b\u4f4d","value":"16.09","date":1757952000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.92","date":1757952000,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.4资金面打败了10%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：09月16日 20:30
| 机构今日流向(万元) | -822.45 | 机构5日流向(万元) | -5138.69 |
| 机构10日流向(万元) | -12894.17 | 机构20日流向(万元) | -40935.41 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加1726.57万股，其中基金净减仓4家，主力净增仓41家，请投资者中长期谨慎为宜。
截止2025-06-30，共165家主力机构（基金157家，一般法人8家），持仓量总计29768.07万股，占流通A股52.58%
其中，基金持仓与2024-12-31相比：
增仓：18家 ，增持 182.23万股
减仓：22家 ，减持 570.37万股
新出现在主力名单中：109家 ，持有2514.63万股
从主力名单中消失：68家 ，原持有415.76万股
其中，基金持仓与2024-12-31相比：
增仓：18家 ，增持 182.23万股
减仓：22家 ，减持 570.37万股
新出现在主力名单中：109家 ，持有2514.63万股
从主力名单中消失：68家 ，原持有415.76万股
消息面诊股
诊断结果：5.5消息面打败了55%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 康缘药业：9月15日获融资买入1077.96万元
2025-09-16 - 研发投入超15%：康缘药业的攻守之道
2025-09-15 - 29个中成药溶液剂亮了！“一哥”易主，两大独家儿科
2025-09-15 - 并购潮+研发热：药企如何布局创新药“黄金赛道”？
2025-09-15 - 行业追踪|中医药市场（9月8日-9月14日）：综合
2025-09-14 - 康缘药业：9月12日获融资买入2902.85万元
2025-09-13 - 康缘药业“中年危机“：主营失速，研发费用连跌五季
2025-09-12 - 康缘药业：9月11日获融资买入2228.28万元
2025-09-12 - 康缘药业主力产品线全面萎缩 关联收购创新药资产后研
2025-09-11 - “后肖伟时代”的康缘药业：主力产品表现不佳，且上半
2025-09-11
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-06-20 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-25 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-04-24 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-03 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-03 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-03 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-03 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.5行业面打败了69%的股票
中药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.09.16","price":"0.04","value":"0.68"},{"date":"2025.09.15","price":"-0.26","value":"-0.41"},{"date":"2025.09.12","price":"-0.12","value":"-0.31"},{"date":"2025.09.11","price":"1.65","value":"0.43"},{"date":"2025.09.10","price":"0.13","value":"0.02"},{"date":"2025.09.09","price":"-0.51","value":"-1.27"},{"date":"2025.09.08","price":"0.38","value":"1.30"},{"date":"2025.09.05","price":"1.24","value":"1.12"},{"date":"2025.09.04","price":"-1.25","value":"-0.37"},{"date":"2025.09.03","price":"-1.16","value":"-1.55"},{"date":"2025.09.02","price":"-0.45","value":"-1.12"},{"date":"2025.09.01","price":"0.46","value":"1.10"},{"date":"2025.08.29","price":"0.37","value":"-0.16"},{"date":"2025.08.28","price":"1.14","value":"-0.71"},{"date":"2025.08.27","price":"-1.76","value":"-2.68"},{"date":"2025.08.26","price":"-0.39","value":"-0.03"},{"date":"2025.08.25","price":"1.51","value":"0.83"},{"date":"2025.08.22","price":"1.45","value":"-0.41"},{"date":"2025.08.21","price":"0.13","value":"-0.21"},{"date":"2025.08.20","price":"1.04","value":"0.26"},{"date":"2025.08.19","price":"-0.02","value":"1.38"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 40.85% | 18.33% | 6.6分 |
| 2 | 仁和药业 | 16.03% | 5.32% | 6.3分 |
| 3 | 天目药业 | 9.35% | 1.93% | 5.7分 |
| 4 | 以岭药业 | 4.98% | -2.29% | 5.8分 |
| 5 | 康美药业 | 4.76% | 8.91% | 6.4分 |
| 6 | - | 4.39% | 4.39% | 分 |
| 8 | 贵州三力 | 3.05% | 4.40% | 6.5分 |
| 10 | 中恒集团 | 1.39% | 6.99% | 6.6分 |
| 12 | ST香雪 | 0.66% | -2.84% | 4.0分 |
| 14 | 步长制药 | 0.43% | -1.36% | 5.6分 |
| 16 | 片仔癀 | -0.53% | -1.39% | 5.1分 |
| 18 | 江中药业 | -1.13% | -1.00% | 5.5分 |
| 20 | 方盛制药 | -1.48% | 0.98% | 5.3分 |
| 22 | 千金药业 | -1.98% | -1.09% | 5.4分 |
| 24 | 昆药集团 | -2.33% | 0.21% | 5.9分 |
| 26 | 羚锐制药 | -2.68% | -2.59% | 5.1分 |
| 28 | 华神科技 | -2.83% | 3.26% | 6.1分 |
| 30 | 东阿阿胶 | -3.44% | -3.26% | 4.7分 |
| 32 | 同仁堂 | -3.81% | -0.85% | 4.6分 |
| 34 | 华润三九 | -3.87% | -2.02% | 5.7分 |
| 36 | 济川药业 | -3.91% | -1.84% | 5.3分 |
| 38 | 吉林敖东 | -4.12% | -0.21% | 5.1分 |
| 40 | 维康药业 | -4.26% | 16.15% | 6.1分 |
| 42 | 白云山 | -4.56% | -2.52% | 5.0分 |
| 44 | 粤万年青 | -5.34% | 0.06% | 5.7分 |
| 46 | 康惠制药 | -5.52% | -0.13% | 5.4分 |
| 48 | *ST长药 | -5.88% | -3.15% | 3.8分 |
| 50 | 奇正藏药 | -6.29% | -2.56% | 6.1分 |
| 52 | 太极集团 | -7.02% | -1.23% | 4.9分 |
| 54 | 莱茵生物 | -7.72% | -0.63% | 5.7分 |
| 56 | 亚宝药业 | -7.93% | -1.01% | 5.3分 |
| 58 | 广誉远 | -8.15% | -1.69% | 5.4分 |
| 60 | 华森制药 | -8.82% | 0.93% | 6.2分 |
| 62 | 陇神戎发 | -9.33% | 0.20% | 5.6分 |
| 64 | 佐力药业 | -10.60% | -1.89% | 4.8分 |
| 66 | 众生药业 | -15.27% | -0.39% | 5.1分 |
| 68 | 康缘药业 | -19.06% | -4.69% | 4.7分 |
| 70 | 新天药业 | -23.30% | 2.28% | 5.0分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 39/112 ， 14/112。
[{"date":"2025-06-30","value":"3.10","vol":"3.94"},{"date":"2025-03-31","value":"1.83","vol":"2.20"},{"date":"2024-12-31","value":"8.07","vol":"4.81"},{"date":"2024-09-30","value":"6.91","vol":"2.92"},{"date":"2024-06-30","value":"5.13","vol":"1.58"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.10 | 1.83 | 8.07 | 6.91 | 5.13 |
| 行业(%) | 3.94 | 2.20 | 4.81 | 2.92 | 1.58 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"70.88","vol":"52.43"},{"date":"2025-03-31","value":"74.18","vol":"52.92"},{"date":"2024-12-31","value":"73.22","vol":"52.40"},{"date":"2024-09-30","value":"74.20","vol":"52.75"},{"date":"2024-06-30","value":"74.55","vol":"53.12"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
70.88 | 74.18 | 73.22 | 74.20 | 74.55 |
| 行业(%) | 52.43 | 52.92 | 52.40 | 52.75 | 53.12 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 59/112 ， 51/112。
[{"date":"2025-06-30","value":"-27.29","vol":"-6.98"},{"date":"2025-03-31","value":"-35.38","vol":"-6.63"},{"date":"2024-12-31","value":"-19.86","vol":"-6.97"},{"date":"2024-09-30","value":"-11.06","vol":"-4.57"},{"date":"2024-06-30","value":"-11.49","vol":"-4.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-27.29 | -35.38 | -19.86 | -11.06 | -11.49 |
| 行业(%) | -6.98 | -6.63 | -6.97 | -4.57 | -4.39 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-40.12","vol":"2.33"},{"date":"2025-03-31","value":"-38.37","vol":"-36.42"},{"date":"2024-12-31","value":"-15.58","vol":"-142.71"},{"date":"2024-09-30","value":"2.18","vol":"63.06"},{"date":"2024-06-30","value":"-3.73","vol":"-13.81"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-40.12 | -38.37 | -15.58 | 2.18 | -3.73 |
| 行业(%) | 2.33 | -36.42 | -142.71 | 63.06 | -13.81 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 35/112 ， 37/112。
[{"date":"2025-06-30","value":"0.24","vol":"0.24"},{"date":"2025-03-31","value":"0.13","vol":"0.12"},{"date":"2024-12-31","value":"0.56","vol":"0.49"},{"date":"2024-09-30","value":"0.44","vol":"0.37"},{"date":"2024-06-30","value":"0.32","vol":"0.26"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.24 | 0.13 | 0.56 | 0.44 | 0.32 |
| 行业(次) | 0.24 | 0.12 | 0.49 | 0.37 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.96","vol":"1.17"},{"date":"2025-03-31","value":"0.43","vol":"0.60"},{"date":"2024-12-31","value":"2.34","vol":"2.40"},{"date":"2024-09-30","value":"1.79","vol":"1.79"},{"date":"2024-06-30","value":"1.35","vol":"1.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.96 | 0.43 | 2.34 | 1.79 | 1.35 |
| 行业(次) | 1.17 | 0.60 | 2.40 | 1.79 | 1.23 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 51/112 ， 62/112。
[{"date":"2025-06-30","value":"8.82","vol":"20.17"},{"date":"2025-03-31","value":"8.77","vol":"0.38"},{"date":"2024-12-31","value":"12.05","vol":"15.45"},{"date":"2024-09-30","value":"25.51","vol":"6.15"},{"date":"2024-06-30","value":"21.30","vol":"11.77"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 8.82 | 8.77 | 12.05 | 25.51 | 21.30 |
| 行业 | 20.17 | 0.38 | 15.45 | 6.15 | 11.77 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.10","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.33","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"2.39","vol":"1.40"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 2.10 | - | 2.33 | - | 2.39 |
| 行业 | 1.02 | 0.00 | 1.46 | 0.00 | 1.40 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 4/112 ， 34/112。
[{"date":"2025-06-30","value":"1.93","vol":"2.88"},{"date":"2025-03-31","value":"1.82","vol":"2.97"},{"date":"2024-12-31","value":"1.76","vol":"2.86"},{"date":"2024-09-30","value":"2.60","vol":"3.22"},{"date":"2024-06-30","value":"2.50","vol":"2.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.93 | 1.82 | 1.76 | 2.60 | 2.50 |
| 行业 | 2.88 | 2.97 | 2.86 | 3.22 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.62","vol":"2.11"},{"date":"2025-03-31","value":"1.50","vol":"2.20"},{"date":"2024-12-31","value":"1.44","vol":"2.09"},{"date":"2024-09-30","value":"2.18","vol":"2.40"},{"date":"2024-06-30","value":"2.10","vol":"2.22"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.62 | 1.50 | 1.44 | 2.18 | 2.10 |
| 行业 | 2.11 | 2.20 | 2.09 | 2.40 | 2.22 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 33/112 ， 35/112。
[{"date":"2025-06-30","value":"28.97","vol":"33.91"},{"date":"2025-03-31","value":"30.42","vol":"33.34"},{"date":"2024-12-31","value":"31.88","vol":"34.08"},{"date":"2024-09-30","value":"22.70","vol":"32.93"},{"date":"2024-06-30","value":"24.36","vol":"33.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
28.97 | 30.42 | 31.88 | 22.70 | 24.36 |
| 行业(%) | 33.91 | 33.34 | 34.08 | 32.93 | 33.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.43","vol":"0.74"},{"date":"2025-03-31","value":"0.46","vol":"0.72"},{"date":"2024-12-31","value":"0.49","vol":"0.74"},{"date":"2024-09-30","value":"0.30","vol":"3.16"},{"date":"2024-06-30","value":"0.33","vol":"1.63"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.43 | 0.46 | 0.49 | 0.30 | 0.33 |
| 行业(%) | 0.74 | 0.72 | 0.74 | 3.16 | 1.63 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华泰金融(HK) | 2025-09-15 | 买入 | 买入 |
| 中信建投证券 | 2025-09-05 | 买入 | |
| 平安证券 | 2025-09-03 | 增持 | |
| 华创证券 | 2025-09-03 | 增持 | |
| 中邮证券 | 2025-08-29 | 买入 | |
| 华泰证券 | 2025-08-29 | 买入 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"3.21","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.34","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.64","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.92","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"4.07","blueLineValue":"0.72","type":"YC"}]